Pixelgen Technologies

Pixelgen Technologies is an emerging biotech firm pioneering high-resolution spatial proteomics through its patented Proximity Network Assay. The company's flagship product, the Proxiome Kit, allows researchers to analyze the abundance, colocalization, and clustering of up to 155 cell surface proteins simultaneously at single-cell resolution, generating up to 50,000 data points per cell. This technology is positioned to unlock novel insights into disease mechanisms, drug mode of action, and biomarker discovery, particularly within immunology and immuno-oncology. Pixelgen operates as a platform and diagnostics tools company, selling kits and analysis services to the research and drug discovery markets.

Proximity Network Assay (Molecular Pixelation): A spatial proteomics platform using DNA-barcoded antibodies to map protein-protein interactions, clustering, and colocalization on the single-cell surface at ~50nm resolution, readout via next-generation sequencing.

Pixelgen competes in the spatial biology and single-cell proteomics space. Direct competitors include companies like Akoya Biosciences (CODEX/Phenocycler) and NanoString (GeoMx) for spatial protein analysis, though their techniques differ. It also faces competition from high-parameter flow/mass cytometry (e.g., Standard BioTools, Fluidigm) for cell surface protein analysis, though these lack Pixelgen's nanoscale spatial interaction data. Its unique value proposition is the combination of high-plex, single-cell, and quantitative protein interaction mapping.